04-12-2008

Dergi Hakkında
Yayın Kurulu
Danışma Kurulu
Yazım Kuralları
Yayın Hakları Devir Formu
Online Makale İşlemleri
İletişim
Oftalmoloji Dergisi
ISSN: 1300-0365
Dil: Türkçe

 
Effects Of Betaxolol And Flunarizine On Visual Fields And Intraocular Pressure In Migraine

Alper Yarangümeli*, Selçuk Çomoğlu**, Özlem Gürbüz Köz*, Atilla Halil Elhan***, Gülcan Kural****
* Uz.Dr., Ankara Numune Eğitim ve Araştırma Hastanesi 1. Göz Kliniği,** Uz.Dr., Ankara Numune Eğitim ve Araştırma Hastanesi Nöroloji Kliniği,*** Arş.Gör., Ankara Üniversitesi Tıp Fakültesi, Biyoistatistik AD,**** Uz.Dr., Ankara Numune Eğitim ve Araştırma Hastanesi 1. Göz Kliniği, Şefi, ANKARA



Purpose: To investigate the effects of topical betaxolol and systemic calcium channel blocker flunarizine on visual fields (VF) and intraocular pressure (IOP) in patients with migraine.
Materials and method: Patients with migraine who were referred to our clinic between June 1999 and June 2000 underwent detailed ophthalmologic examination. IOP measurements and VF tests were performed and patents were divided into four groups. The first group (Group 0) was followed with no medications, topical betaxolol (bid) was precribed to the second group (Group B), oral flunarizine (10 mg daily) was prescribed to the third group (Group F), and the last group (Group BF) was assigned for combined betaxolol and flunarizine treatment. After a mean follow-up time of 4.2±1.2 months (3 to 6 months), ophthalmologic examinations, IOP measurements and VF tests were repeated, and the results of 51 cases (51 eyes) who completed the study were evaluated.
Results: Group B and Group BF were found to be statistically different from the other groups in terms of IOP reduction and VF improvement according to mean deviation and corrected pattern standard deviation indices in the second examinations. On the other hand, Group F and Group BF differed from the other two groups considering the improvement in migrainous complaints.
Conclusion: VF findings which are probably influenced by perfusion problems due to vasospastic mechanisms in migraineurs, improved following topical betaxolol treatment. However, systemic use of flunarizine -a calcium channel blocker- did not seem to be effective on visual fields although it had beneficial effects on migraine.


Keywords: Migraine, Visual field, Betaxolol, Flunarizine

Turkiye Klinikleri J Ophthalmol 2001, 10:190-198

E-mail To Friend This Page Printer Friendly Page
 
 
 ARAMA
  
 Ayrıntılı Arama
 GİRİŞ
 Kullanıcı Adı :
 
 Şifre  
   Beni Hatırla
 Şifremi Unuttum
 Kayıt Ol
 
 
 
 
 
 
 
 

Yasal uyarı: Bu sitede yayınlanan resim, yazı ve diğer uygulamaların her hakkı Ortadoğu Reklam Ve Yayıncılık A.Ş. 'ye aittir. Kaynak gösterilmeden kullanılamaz. Bu site hekimleri sağlık alanında bilgilendirmeye yönelik hazırlanmıştır. Sitede yer alan bilgiler tanı ve tedavi amaçlı kullanıldığında sorumluluk tamamen kullanıcıya aittir. Siteye girmekle bu şartları okumuş, anlamış ve kabul etmiş sayılırsınız.